Cours ProtoKinetix, Incorporated Other OTC
Actions
PKTX
US7437221002
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 6,58 M 5,95 M |
---|---|---|---|---|---|
Résultat net 2022 | -1 M -905 k | Résultat net 2023 | - 0 | VE / CA 2022 | - |
Trésorerie nette 2022 | 25,55 k 23,11 k | Trésorerie nette 2023 | 20,41 k 18,46 k | VE / CA 2023 | - |
PER 2022 |
-4,29
x | PER 2023 |
-1,9
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 60,09% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Clarence Smith
CEO | Chief Executive Officer | 60 | 01/06/14 |
Michael Guzzetta
DFI | Director of Finance/CFO | 66 | 14/11/17 |
Victoria Bantz
LAW | General Counsel | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Clarence Smith
CEO | Chief Executive Officer | 60 | 01/06/14 |
Edward McDonough
BRD | Director/Board Member | 71 | 01/07/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,38% | 48,09 Md | |
+47,41% | 40,62 Md | |
-2,67% | 40,43 Md | |
-6,95% | 28,36 Md | |
+7,81% | 24,89 Md | |
-19,85% | 19,01 Md | |
+29,23% | 12,09 Md | |
-0,83% | 11,88 Md | |
-0,84% | 11,8 Md |